Find research happening in your area that is looking for participants.
It's simple and up to date, just put in your postcode to discover more.
We work with researchers and our local groups to arrange events, such as visits to labs, open days and talks, around the UK. A number of our events are filmed and a select few are streamed live online.
Our local Research Interest Groups connect people affected by Parkinson's with researchers in their local area.
We currently have 8 Research Interest Groups:
- Edinburgh Research Interest Group
- Dundee Research Interest Group
- Glasgow Research Interest Group
- East Midlands Research Support Network
- Yorkshire and the Humber Research Interest Group
- South Wales Research Interest Group
- East England Research Interest Group
- Devon and Cornwall Research Interest Group
If you are interested in starting a new local Research Interest Group, please get in touch with Liz Nash, our Research Support Network Manager, at [email protected].
The Parkinson's UK Brain Bank is the world's only brain bank solely dedicated to Parkinson's research.
Research made possible through the donation of brain tissue has already led to major advances in our understanding of Parkinson's, and resulted in new treatments being developed and tested. Read more about the Brain Bank and why brain donation is important.
Our pioneering Parkinson's Virtual Biotech is investing in the best ideas, wherever they come from, and rapidly turning them into treatments that can be tested and progressed.
As the drug development arm of Parkinson's UK, the Parkinson's Virtual Biotech aims to build a portfolio of projects worth £11million by 2020.
We select and manage projects at the drug discovery, preclinical and early clinical development stages, and work flexibly and creatively with leading research organisations to develop and commercialise new treatments for Parkinson's.
Clinical trials are the most costly and lengthy part of the whole research process. In recent years, several promising new treatments for Parkinson's have failed to show benefit in clinical trials.
Many in the research community believe the problem may not be that the drugs don't work, but that we're testing them in the wrong way.
That's why we fund and lead the Critical Path for Parkinson's.
This international collaboration brings together pharmaceutical companies, regulatory agencies, universities and charities to share data from major studies and trials.
Our expert partner - the Critical Path Institute - is using this data to develop new tools and strategies to improve clinical trials for Parkinson's.
With over 100 blog posts so far, our research blog is the place to go if you are interested in Parkinson's research.
Discover the key challenges and solutions to tackling Parkinson's, find out what the experts have to say, and get the lowdown on stories in the headlines.
Get updates for Parkinson's researchers
Be the first to find out about funding, events, news and opportunities in the world of research by signing up to Synapse - our enewsletter for the Parkinson's research community.